Article info
Original research
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
- Correspondence to Dr Jennifer Chae-Kim, Department of Obstetrics and Gynecology, Baylor Scott & White Medical Center Temple, Temple, Texas, USA; jennifer.chaekim{at}bswhealth.org
Citation
Outcomes of women treated with progestin and metformin for atypical endometrial hyperplasia and early endometrial cancer: a systematic review and meta-analysis
Publication history
- Received April 14, 2021
- Accepted October 6, 2021
- First published November 16, 2021.
Article Versions
- You are currently viewing a Previous version of this article (26 April 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.